Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

2006155 citationsJournal Articlegreen Open Access

Authors

David Devos · Université de Lille

Pierre Krystkowiak · Université de Lille

F. Clement · Université de Lille

Kathy Dujardin · Université de Lille

Olivier Cottencin · Université de Lille

Nawal Waucquier · Université de Lille

K Ajebbar ·

Abstract

Chronic, high doses of MPD improved gait and motor symptoms in the absence of L-dopa and increased the intensity of response of these symptoms to L-dopa in a population with advanced PD.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Botulinum Toxin and Related Neurological Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Neurology Neurosurgery & Psychiatry

Volume 78, Issue 5, pp. 470-475

DOI: 10.1136/jnnp.2006.100016

Field-Weighted Citation Impact: 5.51